Vineet Arora M.D., M.A.P.P.
Dr. Arora, is Associate Professor of Medicine, Assistant Dean of Scholarship & Discovery, and Director of GME Clinical Learning Environment and Innovation at the University Of Chicago. Through funding from AHRQ, NIH, FDA and others, she has developed and evaluated multiple educational interventions to improve medical training while also improving quality, safety, and value of care in teaching hospitals. She has over 100 peer-reviewed publications and her work has received coverage by the New York Times, NPR, and the Associated Press. For her body of work, she has been recognized by HealthLeader Magazine in 2011 as “20 People Who Make American Healthcare Better” and is the past recipient of the American College of Physicians Walter J. McDonald Young Physician Award, Society of General Internal Medicine’s Mid-Career Mentoring Award, the Society of Hospital Medicine’s Excellence in Hospital Medicine Research Award.
As the Director of Educational Initiatives at Costs of Care, she oversaw the development of the Teaching Value web modules, which are easy to access free e-learning tools to promote cost conscious prescribing and reduce waste and co-chaired the Teaching Value Choosing Wisely Challenge. She is co-author of Understanding High Value Care, a textbook from McGraw Hill released in 2015. An avid user of social media, Dr. Arora regularly tweets about medical education, technology, and health policy at @futuredocs.
William Shrank, M.D.
Dr. William Shrank joined UPMC’s Health Plan Division in June 2016 as the company’s new Chief Medical Officer. In this role, Dr. Shrank will focus on the design and implementation of new payment and delivery models to promote improved population health and further advance UPMC’s integrated clinical business strategies.
Prior to joining UPMC, Dr. Shrank served as Senior Vice President, Chief Scientific Officer and Chief Medical Officer of Provider Innovation for CVS Health where he led the development of solutions to support providers manage risk and deliver better care for the populations they serve. Prior to joining CVS, Dr. Shrank served as the inaugural Director, Research and Rapid-Cycle Evaluation for the Center for Medicare & Medicaid Innovation at the Centers for Medicare & Medicaid Services (CMS) where he helped design and led the evaluation of new payment reform models tested by the Center such as Pioneer ACOs, Bundled Payments and progressive Primary Care models. Dr. Shrank began his career as a practicing physician with Brigham Internal Medicine Associates at Brigham and Women’s Hospital in Boston, as well as an Assistant Professor at Harvard Medical School. His research at Harvard focused on improving the quality of prescribing and the use of chronic medications and he published nearly 200 papers on these topics.
Dr. Shrank received his medical degree from Cornell University Medical College, served his residency in Internal Medicine at Georgetown University and was a fellow in Health Policy Research at UCLA, RAND. He earned his Master of Science degree in Health Services from the University of California at Los Angeles and his Bachelor’s Degree from Brown University.
Dr. Shrank has served on various national committees and advisory boards, such as the National Advisory Committee for FDA, CMS, White House (Networking Information, Technology Research and Development Program), DHHS and AHRQ. Among the many achievement awards Dr. Shrank received is the 2015 Healthcare Executive Transformation Award from the Los Angeles County Medical Association. He also was the recipient of the Robert Wood Johnson Pioneer Award to evaluate the effect of innovative prescription label design on adherence to chronic medication and health outcomes.
Tom Shehab, M.D.
Tom Shehab joined Arboretum Ventures in 2014 as a Principal. Previously, Tom served as a member of Arboretum’s Technical Advisory Board and as a board member of an Arboretum portfolio company, ArborMetrix. In his current role, Tom draws upon his clinical, healthcare administration and operational expertise to evaluate new potential investments and provide strategic support to Arboretum’s portfolio companies. Prior to joining Arboretum, Tom spent 12 years as a physician executive and practicing physician specializing in gastroenterology. He was involved in a number of entrepreneurial healthcare-related ventures and held multiple senior leadership roles. Most recently, Tom served as Chief of Staff for more than 1,000 physicians at St. Joseph Mercy Hospital in Ann Arbor and as the Chair of Medicine for Integrated Health Associates (IHA), a multi-specialty group consisting of 300+ providers. Both St. Joseph Mercy Hospital and IHA are part of Trinity Health. Tom earned an M.D. from Wayne State University, performed his residency and fellowship training at the University of Michigan Medical Center, and earned his Master’s in Medical Management from the Heinz School of Management at Carnegie Mellon University.
Mark Sutter, M.B.A., M.S.
Mark A. Sutter is the President and CEO of Terumo Cardiovascular Group, on of several subsidiaries of Terumo Corporation of Japan focused on cardiac and vascular specialties. He has overseen all aspects of the global business, including operations, technology development and commercialization, global product introductions, acquisitions and partnerships, and long- and short-term strategic planning.
Under his 15-year leadership, Terumo has become the world’s leading brand for cardiac surgery devices. Its product portfolio includes a number of highly differentiated products, many of which introduced new technologies that are now broadly adopted by cardiac clinicians worldwide.
Mark is a sought-after advisor and speaker, both regionally and nationally. He has served as: Advisory Board Member for the BioEngineering School at the University of Michigan; Executive Review Committee Member for Colter Medical Device Translational Research; and Board Member for NuStep, Inc. He has been an invited speaker at University of Michigan Business School Lecture Series, the William Davidson International Institute, and numerous medical device conferences.
Mark has earned two Masters degrees from the University of Michigan: a Master of Science in Bioengineering as well as a Master of Business Administration.
Terumo Cardiovascular Group manufactures and markets medical devices for cardiac and vascular surgery with an emphasis on cardiopulmonary bypass, intra-operative monitoring and vascular grafting. The company is headquartered in Ann Arbor, Michigan, with manufacturing operations in the U.S., Europe and Asia.